9th IPF Summit

As part of a busy season of scientific exchange, Nordic Bioscience’s pulmonary team is excited to attend the 9th Annual IPF Summit, taking place in Boston from August 19–21, 2025.

This summit brings together leading voices in pulmonary fibrosis to explore the latest in drug development, translational models, and biomarker strategies. Our team will be there to contribute to the conversation and highlight the role of biomarkers in advancing IPF research.

In particular, we’ll be sharing insights on FIB-NIT™, our non-invasive biomarker panel designed to capture both fibrogenesis and fibrolysis in real time. Already applied in liver and lung fibrosis research, FIB-NIT™ provides a dynamic and translational tool for tracking disease progression and therapeutic response in IPF trials. Learn more about the panel here.

We look forward to connecting with researchers, clinicians, and partners during this event.